Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,190.65 +9.91 (+0.19%) Dow
38,911.07 +58.80 (+0.15%) Nasdaq
16,341.16 -8.08 (-0.05%) Bitcoin USD
63,058.80 -106.56 (-0.17%) CMC Crypto 200
1,309.29 -55.84 (-4.09%)
Biotech and drug stocks
7.45k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Biotech and drug stocks | +0.47% | - | - | - |
| ^GSPC | +0.19% | -0.23% | +25.44% | +5481.34% |
31 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 777.74 | +11.06 | +1.44% | 3:58 pm GMT-4 | 2.29M | 2.95M | 739.17B |
| NVO | Novo Nordisk A/S | 127.46 | +2.87 | +2.30% | 3:58 pm GMT-4 | 3.85M | 4.79M | 568.61B |
| JNJ | Johnson & Johnson | 148.6385 | +0.06 | +0.04% | 3:58 pm GMT-4 | 4.04M | 7.63M | 357.73B |
| MRK | Merck & Co., Inc. | 130.42 | +2.85 | +2.23% | 3:58 pm GMT-4 | 4.79M | 8.21M | 330.33B |
| ABBV | AbbVie Inc. | 162.43 | -0.30 | -0.18% | 3:58 pm GMT-4 | 3.31M | 5.70M | 286.83B |
| AZN | AstraZeneca PLC | 76.345 | +0.58 | +0.77% | 3:58 pm GMT-4 | 5.13M | 6.57M | 236.71B |
| NVS | Novartis AG | 99.14 | +1.41 | +1.44% | 3:58 pm GMT-4 | 1.04M | 1.62M | 202.29B |
| RHHBY | Roche Holding AG | 30.45 | +0.36 | +1.20% | 3:43 pm GMT-4 | 1.07M | 2.85M | 196.81B |
| AMGN | Amgen Inc. | 300.39 | +0.91 | +0.30% | 3:58 pm GMT-4 | 1.96M | 2.92M | 161.14B |
| PFE | Pfizer Inc. | 27.795 | -0.36 | -1.30% | 3:58 pm GMT-4 | 49.36M | 41.86M | 157.39B |
| SNY | Sanofi | 49.58 | +0.25 | +0.51% | 3:58 pm GMT-4 | 1.15M | 2.08M | 123.77B |
| REGN | Regeneron Pharmaceuticals, Inc. | 969.27 | +10.63 | +1.11% | 3:58 pm GMT-4 | 267.29k | 468.77k | 106.80B |
| VRTX | Vertex Pharmaceuticals Incorporated | 410.11 | +7.61 | +1.89% | 3:58 pm GMT-4 | 1.39M | 1.04M | 106.00B |
| GSK | GSK plc | 44.155 | +0.70 | +1.62% | 3:58 pm GMT-4 | 2.77M | 3.36M | 90.09B |
| BMY | Bristol-Myers Squibb Company | 44.02 | +0.12 | +0.27% | 3:58 pm GMT-4 | 8.61M | 15.60M | 89.23B |
| GILD | Gilead Sciences, Inc. | 65.53 | -0.01 | -0.02% | 3:58 pm GMT-4 | 4.35M | 7.32M | 81.71B |
| ZTS | Zoetis Inc. | 168.69 | +2.74 | +1.65% | 3:58 pm GMT-4 | 2.59M | 3.73M | 76.97B |
| MRNA | Moderna, Inc. | 121.095 | -1.03 | -0.85% | 3:58 pm GMT-4 | 2.41M | 3.99M | 46.41B |
| TAK | Takeda Pharmaceutical Company Limited | 13.285 | -0.07 | -0.56% | 3:58 pm GMT-4 | 1.61M | 1.63M | 41.90B |
| HLN | Haleon plc | 8.325 | +0.09 | +1.03% | 3:58 pm GMT-4 | 4.91M | 6.08M | 38.17B |
| BIIB | Biogen Inc. | 218.79 | -2.63 | -1.19% | 3:58 pm GMT-4 | 897.69k | 1.31M | 31.86B |
| BAYRY | Bayer Aktiengesellschaft | 7.71 | +0.10 | +1.31% | 3:42 pm GMT-4 | 1.25M | 2.07M | 30.30B |
| ARGX | argenx SE | 398.61 | +4.83 | +1.23% | 3:58 pm GMT-4 | 188.19k | 263.48k | 23.69B |
| BNTX | BioNTech SE | 90.96 | -2.39 | -2.56% | 3:58 pm GMT-4 | 423.02k | 606.98k | 21.92B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 154.3 | +3.08 | +2.04% | 3:58 pm GMT-4 | 252.23k | 814.27k | 19.52B |
| GMAB | Genmab A/S | 29.24 | +0.21 | +0.72% | 3:58 pm GMT-4 | 599.13k | 561.00k | 18.88B |
| ALPMY | Astellas Pharma Inc. | 10.064 | - | - | 3:38 pm GMT-4 | 568.08k | 326.13k | 18.19B |
| BGNE | BeiGene, Ltd. | 160.68 | -1.80 | -1.11% | 3:58 pm GMT-4 | 93.43k | 215.06k | 17.77B |
| RPRX | Royalty Pharma plc | 28.27 | -0.22 | -0.77% | 3:58 pm GMT-4 | 1.89M | 2.83M | 16.89B |
| BMRN | BioMarin Pharmaceutical Inc. | 82.67 | +0.57 | +0.69% | 3:58 pm GMT-4 | 690.70k | 1.55M | 15.70B |
Insider Monkey15 Best S&P 500 Dividend Stocks To Buy Now
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]
BenzingaWhat About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month
Tuesday, the FDA said it would convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee on Monday, June 10, 2024, to discuss Eli Lilly and Co’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually. The Phase 3 study submitted as part of this application, TRAILBLAZER-ALZ 2, is a double-blind, placebo-controlled study to evaluate the safety and efficacy of donanemab in pa
GlobeNewswireCapital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; May 7, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,959 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 2,171 shares at DKK 1,025.00,2,790 shares at DKK 1,032.00,98 shares at DKK 1,161.00,729 shares at DKK 1,334.50,343 sh
